[ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Hofman, Michael S, Violet, John, Hicks, Rodney J, Ferdinandus, Justin, Ping Thang, Sue, Akhurst, Tim, Iravani, Amir, Kong, Grace, Ravi Kumar, Aravind, Murphy, Declan G, Eu, Peter, Jackson, Price, ScalLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30198-0
Date:
May, 2018
File:
PDF, 797 KB
english, 2018